Identification of Genomic Predictors of Adverse Events After Cardiac Surgery (CABG Genomics)
This study is currently recruiting participants.
Verified December 2012 by Brigham and Women's Hospital
Sponsor:
Brigham and Women's Hospital
Collaborators:
Texas Heart Institute
Information provided by (Responsible Party):
Simon Body, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT01258231
First received: December 9, 2010
Last updated: December 31, 2012
Last verified: December 2012
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | December 9, 2010 | ||||
| Last Updated Date | December 31, 2012 | ||||
| Start Date ICMJE | August 2000 | ||||
| Estimated Primary Completion Date | August 2020 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
|
||||
| Original Primary Outcome Measures ICMJE |
|
||||
| Change History | Complete list of historical versions of study NCT01258231 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Identification of Genomic Predictors of Adverse Events After Cardiac Surgery | ||||
| Official Title ICMJE | Identification of Genomic Predictors of Adverse Events After Cardiac Surgery | ||||
| Brief Summary | This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Cohort Time Perspective: Prospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Retention: Samples With DNA Description: DNA, buffy coat, plasma and serun |
||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | Adult patients undergoing heart surgery |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) | Adult patients undergoing cardiac surgery | ||||
| Publications * |
|
||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Recruiting | ||||
| Estimated Enrollment ICMJE | 4000 | ||||
| Estimated Completion Date | August 2020 | ||||
| Estimated Primary Completion Date | August 2020 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 20 Years to 90 Years | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Not Provided | ||||
| Location Countries ICMJE | United States | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01258231 | ||||
| Other Study ID Numbers ICMJE | 2000P001639 | ||||
| Has Data Monitoring Committee | Yes | ||||
| Responsible Party | Simon Body, Brigham and Women's Hospital | ||||
| Study Sponsor ICMJE | Brigham and Women's Hospital | ||||
| Collaborators ICMJE |
|
||||
| Investigators ICMJE |
|
||||
| Information Provided By | Brigham and Women's Hospital | ||||
| Verification Date | December 2012 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||